Amarin Beats Class Claims Of Duping Investors At 3rd Circ.
Drugmaker Amarin Corp. beat a proposed stockholder class action at the Third Circuit on Tuesday, with a panel ruling that the company's statements about a drug's trial were not misleading just...To view the full article, register now.
Already a subscriber? Click here to view full article